Analysis Article • Jul 14
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 27, 2026
DataAggregated Company Financials
Companies7
- 7D-3.3%
- 3M-8.2%
- 1Y-45.3%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 3.3%, driven by a pullback from Oxford Nanopore Technologies of 4.0%. On the other hand hVIVO is actually up 12%. The industry has fallen 45% in the last year. Earnings are forecast to grow by 51% annually.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 27 Jul 2026 | UK£1.3b | UK£323.1m | -UK£164,731,254.00 | 1126x | -7.6x | 3.9x |
| Wed, 24 Jun 2026 | UK£1.3b | UK£323.0m | -UK£166,018,254.00 | 1261.3x | -8x | 4.1x |
| Fri, 22 May 2026 | UK£1.5b | UK£318.9m | -UK£167,635,254.00 | n/a | -8.8x | 4.6x |
| Sun, 19 Apr 2026 | UK£1.5b | UK£318.2m | -UK£167,469,254.00 | n/a | -8.8x | 4.6x |
| Tue, 17 Mar 2026 | UK£1.4b | UK£324.0m | -UK£161,423,254.00 | 10.3x | -8.4x | 4.2x |
| Thu, 12 Feb 2026 | UK£1.6b | UK£304.6m | -UK£159,441,254.00 | 11.4x | -9.8x | 5.1x |
| Sat, 10 Jan 2026 | UK£1.6b | UK£304.6m | -UK£159,441,254.00 | 8x | -9.9x | 5.2x |
| Mon, 08 Dec 2025 | UK£1.4b | UK£304.3m | -UK£160,776,254.00 | 6.4x | -8.7x | 4.6x |
| Wed, 05 Nov 2025 | UK£1.5b | UK£304.3m | -UK£163,156,254.00 | 8.4x | -9.4x | 5.1x |
| Fri, 03 Oct 2025 | UK£1.7b | UK£304.0m | -UK£163,375,352.00 | 10x | -10.5x | 5.6x |
| Sun, 31 Aug 2025 | UK£2.0b | UK£291.9m | -UK£160,968,352.00 | 6.3x | -12.2x | 6.7x |
| Tue, 29 Jul 2025 | UK£2.3b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -14.1x | 7.8x |
| Thu, 26 Jun 2025 | UK£1.6b | UK£319.2m | -UK£190,522,602.40 | 7.4x | -8.3x | 5x |
| Sat, 24 May 2025 | UK£1.7b | UK£319.4m | -UK£190,818,893.50 | 10.9x | -8.7x | 5.2x |
| Mon, 21 Apr 2025 | UK£1.6b | UK£314.9m | -UK£185,639,007.85 | 6.3x | -8.5x | 5x |
| Wed, 19 Mar 2025 | UK£1.6b | UK£315.4m | -UK£186,022,309.85 | 6x | -8.7x | 5.1x |
| Fri, 14 Feb 2025 | UK£1.9b | UK£306.9m | -UK£195,489,257.52 | 7.1x | -9.6x | 6.1x |
| Sun, 12 Jan 2025 | UK£1.9b | UK£307.7m | -UK£196,115,709.60 | 7.1x | -9.7x | 6.2x |
| Tue, 10 Dec 2024 | UK£2.0b | UK£306.0m | -UK£194,805,985.20 | 8.3x | -10.1x | 6.5x |
| Thu, 07 Nov 2024 | UK£1.9b | UK£304.9m | -UK£192,723,260.50 | 10.8x | -9.8x | 6.2x |
| Sat, 05 Oct 2024 | UK£2.1b | UK£304.3m | -UK£192,222,280.30 | 10.8x | -10.7x | 6.8x |
| Mon, 02 Sep 2024 | UK£1.8b | UK£295.7m | -UK£188,377,847.70 | 12.4x | -9.5x | 6.1x |
| Wed, 31 Jul 2024 | UK£1.8b | UK£295.5m | -UK£189,894,554.43 | 12.7x | -9.3x | 6x |
| Fri, 28 Jun 2024 | UK£1.5b | UK£296.0m | -UK£190,332,627.09 | 11.4x | -7.9x | 5.1x |
| Sun, 26 May 2024 | UK£1.7b | UK£295.6m | -UK£189,818,792.31 | 11.3x | -8.7x | 5.6x |
| Tue, 23 Apr 2024 | UK£1.5b | UK£318.0m | -UK£178,762,280.21 | 11.3x | -8.1x | 4.6x |
| Thu, 21 Mar 2024 | UK£1.9b | UK£295.5m | -UK£212,846,040.67 | 7178x | -8.9x | 6.4x |
| Sat, 17 Feb 2024 | UK£2.1b | UK£286.0m | -UK£189,371,602.11 | 6964.1x | -11x | 7.3x |
| Mon, 15 Jan 2024 | UK£2.9b | UK£449.9m | -UK£173,931,009.00 | 67.7x | -16.9x | 6.5x |
| Wed, 13 Dec 2023 | UK£2.9b | UK£453.0m | -UK£170,801,951.00 | 47.3x | -17x | 6.4x |
| Fri, 10 Nov 2023 | UK£3.0b | UK£456.2m | -UK£169,311,778.00 | 47.3x | -18x | 6.7x |
| Sun, 08 Oct 2023 | UK£2.9b | UK£458.5m | -UK£165,463,545.00 | 54.3x | -17.5x | 6.3x |
| Tue, 05 Sep 2023 | UK£3.3b | UK£476.4m | -UK£126,700,530.00 | 70.6x | -25.9x | 6.9x |
| Thu, 03 Aug 2023 | UK£3.3b | UK£476.6m | -UK£124,762,400.00 | 69.6x | -26.7x | 7x |
Price to Earnings Ratio
-26.7x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.7x is higher than the industry's current PS ratio of 3.9x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 1.20% | |
| Healthcare | 0.051% | |
| Life Sciences | -3.33% | |
| Clinical Research and Equipment | -3.33% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| HVO hVIVO | UK£0.075 | 13.6% +UK£6.2m | -25.0% | PS1x | |
| FAB Fusion Antibodies | UK£0.11 | 2.4% +UK£312.6k | 10.3% | PS8.4x |